Viewing Study NCT00448617



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00448617
Status: COMPLETED
Last Update Posted: 2015-05-29
First Post: 2007-03-15

Brief Title: Cigarette Smoke and Susceptibility to Influenza Infection
Sponsor: University of North Carolina Chapel Hill
Organization: University of North Carolina Chapel Hill

Study Overview

Official Title: Cigarette Smoke and Susceptibility to Influenza Infection
Status: COMPLETED
Status Verified Date: 2015-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will be a descriptive comparison of the effects of live attenuated influenza virus FluMist on nasal inflammation and oxidative stress in healthy young adults who are not exposed to smoke vs smokers It is hypothesized that passive exposure to second-hand smoke SHS results in increased susceptibility to the effects of influenza virus in nasal epithelium in humans and that these effects are mediated by SHS-induced oxidative stress
Detailed Description: Epidemiologic evidence supports a significant relationship between passive cigarette smoke exposure and increased risk for viral respiratory illnesses Published and preliminary data suggest that airborne pollutants including tobacco smoke increase susceptibility of respiratory epithelium to infection with influenza A and that this effect is at least partially mediated by oxidative stress However no studies have specifically looked at the interaction between smoking and the effects of influenza virus in human volunteers

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None